The global medical devices industry was valued at $545.38 billion in 2024 and is expected to reach $801.34 billion in 2029. Companies continue to focus on and invest in new product development to ensure long-term and sustained growth. The cardiovascular devices market attracted significant investments, especially in transcatheter technologies for mitral and tricuspid valves, pulsed field ablation, and bioresorbable scaffolds.

Key segments, including cardiovascular devices, diabetes care devices, robotics, and clinical-grade wearables, posted double-digit growth on a significantly higher revenue base, while neurology and respiratory devices posted high single-digit growth. Major geographic regions, including North America, Europe, and Asia-Pacific, registered high single-digit growth.

• How are practice areas like patient monitoring, diabetes care, orthopedic devices, minimally invasive surgeries, ophthalmology, cardiovascular devices, wound care, respiratory, audiology, clinical-grade wearables, neurology, robotics, and navigation systems poised for growth?
  
• What impact will the expanding use of clinical-grade wearables across various care settings have on the growth of the medical devices space?
  
• How will AI-enabled predictive maintenance in the medical device servicing industry pave the way for growth?